Hacibekiroglu, IlhanKodaz, HilmiErdogan, BulentTurkmen, EsmaOzcelik, MelikeEsenkaya, AsimSaygi, Haci Mehmet2024-06-122024-06-1220151357-05601559-131Xhttps://doi.org/10.1007/s12032-015-0482-5https://hdl.handle.net/20.500.14551/25560[Abstract Not Available]en10.1007/s12032-015-0482-5info:eu-repo/semantics/openAccess[No Keywords]Single-agent bevacizumab is an effective treatment in recurrent glioblastoma (vol 32, 12, 2015)Correction324Q3WOS:0003514741000332-s2.0-8492586842925782869Q2